Could a hormone and a sleep aid prevent brain surgery in preemies?
NCT ID NCT05617833
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tests whether giving two medicines—erythropoietin and melatonin—together is safe for very premature babies who have bleeding in the brain. About 60 infants will receive either the drug combination or a placebo, along with standard care, to see if the treatment causes serious side effects. If safe, future studies will check if this approach can prevent the need for lifelong brain shunts.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRAVENTRICULAR HEMORRHAGE OF PREMATURITY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Johns Hopkins All Children's Hospital
RECRUITINGSt. Petersburg, Florida, 33701, United States
-
Johns Hopkins Hospital
RECRUITINGBaltimore, Maryland, 21287, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.